Drug Policy Archives - Page 2 of 47 - Reason Foundation

The hidden costs of New York’s cannabis social equity program

Commentary by Michelle Minton

Psychedelics Policy Newsletter: A glimpse into Colorado after psychedelics legalization, a gathering of conservative legislators, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — July 2024

Commentary by Gregory Ferenstein

Colorado could improve regulatory rules regarding psychedelic use

Testimony by Leonard Gilroy, Geoffrey Lawrence, Gregory Ferenstein and Madison Carlino

A glimpse into Colorado’s emerging legal pyschedelics scene

Commentary by Gregory Ferenstein

How the FDA can safely approve a promising but controversial mental health drug

Commentary by Gregory Ferenstein and Geoffrey Lawrence

A Schedule III designation is still overly restrictive for marijuana

Testimony by Geoffrey Lawrence and Jacob James Rich

States can legalize MDMA for pharmaceutical use even if the federal government does not

Commentary by Gregory Ferenstein

New Jersey Senate Bill 2283 would decriminalize psilocybin

Testimony by Leonard Gilroy, Geoffrey Lawrence and Gregory Ferenstein

More Drug Policy

Prev
1
2
3
4
5
6
7
...
47
Next